Allogene Therapeutics (ALLO) EPS (Basic) (2018 - 2026)
Allogene Therapeutics (ALLO) posted EPS (Basic) of -$0.6 for Q1 2026, down 162.02% sequentially from -$0.23 in Q4 2025, and down 76.45% YoY from -$2.57 in Q1 2025.
Allogene Therapeutics (ALLO) EPS (Basic) (2018 - 2026) Analysis & Trends
Allogene Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.6 in Q1 2026.
- Quarterly EPS (Basic) fell 76.45% year-over-year to -$0.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.41 (up 24.71% YoY) and the FY2025 annual result came in at -$0.87, up 34.57% from the prior year.
- EPS (Basic) fell to -$0.6 in Q1 2026 per ALLO's latest filing, from -$0.23 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.23 in Q4 2025 and troughed at -$1.57 in Q3 2022.
- A 5-year average of -$0.59 and a median of -$0.55 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) plunged 3211.29% in 2022, then surged 65.51% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.7 in 2022, then soared by 33.91% to -$0.46 in 2023, then soared by 36.36% to -$0.3 in 2024, then climbed by 21.92% to -$0.23 in 2025, then sank by 162.02% to -$0.6 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.6, -$0.23, and -$0.29 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Allogene Therapeutics | 707.96 Mn | 707.96 Mn | - | -0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.59 |
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.23 |
| Sep 30, 2025 | -0.29 |
| Jun 30, 2025 | -0.35 |
| Mar 31, 2025 | -0.34 |
| Dec 31, 2024 | -0.30 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -1.01 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.77 |
| Mar 31, 2023 | -0.69 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -1.57 |
| Jun 30, 2022 | -0.76 |
| Mar 31, 2022 | -0.58 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | -1.17 |